DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
DEBIO-1347 is an investigational drug.
There have been 20 clinical trials for DEBIO-1347. The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2007.
The most common disease conditions in clinical trials are Bacterial Infections, Carcinoma, Non-Small-Cell Lung, and Communicable Diseases. The leading clinical trial sponsors are Debiopharm International SA, Centre Leon Berard, and Merck Sharp & Dohme Corp.
Recent Clinical Trials for DEBIO-1347
|Study of Oral Debio 0123 in Combination With Carboplatin in Participants With Advanced Solid Tumors||Debiopharm International SA||Phase 1|
|Study to Assess Safety and Efficacy of the Second Mitochondrial-derived Activator of Caspases (SMAC) Mimetic Debio 1143||Debiopharm International SA||Phase 1/Phase 2|
|Pembrolizumab In Combination With Debio 1143 In Pancreatic and Colorectal Advanced/Metastatic Adenocarcinoma||Debiopharm International SA||Phase 1|